Futura Medical (LON:FUM) Shares Down 9.7% – Here’s Why

Shares of Futura Medical plc (LON:FUM) fell 9.7% during trading on Tuesday . The stock traded as low as GBX 0.24 and last traded at GBX 0.50. 7,041,876 shares traded hands during mid-day trading, a decline of 18% from the average session volume of 8,535,829 shares. The stock had previously closed at GBX 0.55.

Futura Medical Stock Down 9.7%

The company has a market capitalization of £2.91 million, a PE ratio of -0.18 and a beta of 0.02. The company’s 50 day moving average is GBX 0.69 and its two-hundred day moving average is GBX 1.04.

Futura Medical (LON:FUM) last announced its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The company had revenue of GBX 170 million during the quarter. Analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.